Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > How long before covid-19test sales start to dry up for SZLS?
View:
Post by StockscoutX on Jun 09, 2021 2:34pm

How long before covid-19test sales start to dry up for SZLS?

StageZero has serious competition.

Here is an excerpt:

How much does a viral test for COVID-19 cost?

There is a wide range in charges. An investigation by the Kaiser Family Foundation determined that the cost of a test can range anywhere from $20 to $850, with $127 being the median cost. Currently, the Medicare reimbursement rate for a COVID-19 test is either $51 or $100, depending on the type of test offered. For those who end up paying out of pocket, there was a smaller range of $36 to $180 per test. Again, any test would also likely require additional charges for specimen collection and a physician’s visit, which could potentially add to the cost significantly.

Here is the link: 
Q&A: How much does it cost to get a COVID-19 test? It depends. - Johns Hopkins Coronavirus Resource Center (jhu.edu)

or

https://coronavirus.jhu.edu/from-our-experts/q-and-a-how-much-does-it-cost-to-get-a-covid-19-test-it-depends

Comment by Mykndrsn on Jun 09, 2021 2:49pm
Aristotle and Care revenues will make Covid testing income irrelevant.
Comment by Mermer2328 on Jun 09, 2021 3:30pm
thankyou!! finally someone on the same page. We are a CANCER detection company. Forget Covid, we need only info surrounding Aristotle
Comment by IainCaimbeul on Jun 09, 2021 3:00pm
Covid testing is now a commodity, almost a side issue. Everybody and his dog is in on the act. Cheaper tests could could be detrimental to Stage unless we focus on our real mission - liquid biopsies. Aristotle is unique, a market leader waiting to bust out.
Comment by LithLover on Jun 09, 2021 3:12pm
Well said.  But they can continue to add the extra revenue, as it allowed them to be cash flow positive last quarter.  Get Shift to ramp up the promotional piece and the Care deal closed.  As covid testing reduces Aristotle increases.  Need confirmation of the closing of the deal and that testing has begun.
Comment by gojotv! on Jun 09, 2021 3:37pm
Now that you've read StockscumX's lies, here's the truth. Covid tests have a wide price range because there are different kinds of tests. For travel, a PCR test from a recognized lab is needed, not a cheaper antigen test. As for duration...Mexico and Southern destinations have been hit hard by Covid. Florida and Disney destinations DO NOT want the scandal of being "spreader" ...more  
Comment by IainCaimbeul on Jun 09, 2021 3:49pm
"here's the truth" from the biggest liar on the board, poor little gojotv. A complete waste of space.
Comment by StockscoutX on Jun 09, 2021 4:17pm
All the pumping and name calling gojotv! will not help you recover your losses. It's a fact that StageZero has a pricey test kit and competitors with better pricing could easily cut into their actual market share going forward. It doesn't look good going forward for revenue making on convid-19 tests for StageZero. They better get up to speed with Aristotle or else they will be checkmated ...more  
Comment by gojotv! on Jun 09, 2021 5:11pm
If you did your DD like I did, you'd see why StockscroteX is a liar. Approved labs don't just spring out of the earth. SZLS is the right product, deployed over the right territory, offering the right convenience to MUSHROOM revenues over the coming year. Do your own DD, and you'll be back soon to buy shares.... Like StockscroteX clearly did... because he's here every day... to get ...more  
Comment by Zedd3333 on Jun 09, 2021 5:25pm
This post has been removed in accordance with Community Policy
Comment by IainCaimbeul on Jun 09, 2021 7:26pm
Heh bozotv why don't you just STF up with your puerile comments. Anybody who would take advice from you would have to be as twisted as you.
Comment by LithLover on Jun 09, 2021 6:23pm
OMG are you that dense.  We have $6 million in the bank and were positive EBITDA for Q1.  Even if we drop off a bit in Q2 and Q3 and need to burn $1 million we have 1-2 years of funding.   The Covid revenue is paying the bills while these partnerships and Aristotle gets rolled out.  It's not our primamry business.  Your continually bashing is getting old.  & ...more  
Comment by Nailbiter1 on Jun 09, 2021 7:43pm
This post has been removed in accordance with Community Policy
Comment by LithLover on Jun 09, 2021 8:14pm
Agree.  I got my 2nd shot a couple weeks ago.  All good to go.  I wouldn't think twice to grab the double test from Rexall before heading to Hawaii, Florida or Vegas.  Once the wife agrees she is comfortable to travel we are heading out with the extra savings from 15 months of no travel, very little restuarants and limited shopping.   I'm sure we are not alone ...more  
Comment by Bogeyfree1 on Jun 09, 2021 7:49pm
Lithlover wrote: "We have $6 million in the bank and we're positive EBITDA for Q1." Can you then tell me why we're sitting at this ridiculous SP? Not being sarcastic, I just would like a plausible explanation if anyone can respectfully give me one (other than Tripp)? Thank you!
Comment by Bogeyfree1 on Jun 09, 2021 7:50pm
Lithlover wrote: "We have $6 million in the bank and we're positive EBITDA for Q1." Can you then tell me why we're sitting at this ridiculous SP? Not being sarcastic, I just would like a plausible explanation if anyone can respectfully give me one (other than Tripp)? Thank you!
Comment by LithLover on Jun 09, 2021 8:17pm
Jack Lifton said it best.  Exposure.  I've said for months we need more marketing and Tripp must have heard me and hired Shift.  More exposure and trading on a US exchange and we will see the increased interest.  All this naked shorting will help with a nice little squeeze too. Oh right there are no shorts here.  Just like there is only like 10% short in AMC and GME ...more  
Comment by IainCaimbeul on Jun 09, 2021 9:36pm
Chatty Jack Lifton also said "Aristotle will literally sell itself". Hope so, but in the meantime I remain yours faithfully the sceptic on that one. Oh yeah: short shorter, short shorter, short shorter; DD, DD, DD; basher, basher, basher; pumper, pumper, pumper... suggest certain folks on this board take those words out of their vocabulary; really getting boring. Shorters are a fact of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities